The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...
The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...
A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a c ...
Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ... By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study ...
1d
AllAfrica on MSNAfrica: U.S. Funding Cuts Imperil Search for HIV VaccineBlog - A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt ...
4d
Tribune Online on MSNWhy is Aids a syndrome?Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results